Journal of Infection and Public HealthBioinformaticsPeer-reviewed journal article
Unlocking Antiviral Potentials of Traditional Plants: A Multi-Method Computational Study against Human Metapneumovirus (HMPV)
Amit DubeyiD, Manish KumariD, Aisha TufailiD, Vivek Dhar DwivediiD, Andrea RagusaiD
- Citations
- 15
- FWCI
- 7.72
- Field percentile
- top 2%
Abstract
Human metapneumovirus (HMPV) remains a critical challenge in respiratory healthcare, particularly due to the lack of targeted antiviral therapies and vaccines. This study employs an integrative computational framework to identify and evaluate the antiviral potential of nature-based compounds derived from traditional medicinal plants. A suite of advanced methodologies, including virtual screening, molecular docking, molecular dynamics (MD) simulations, density functional theory (DFT) calculations, pharmacophore modeling, and ADMET profiling, was utilized to comprehensively analyze candidate compounds. Among the tested compounds, Glycyrrhizin exhibited exceptional properties, with a binding energy of -65.4 kcal/mol, eight stabilizing hydrogen bonds, and remarkable dynamic stability (RMSD 1.3 [A]). Similarly, Withaferin A demonstrated a binding energy of -63.7 kcal/mol and high pharmacokinetic potential. Quantum-level analyses revealed favorable electronic properties, while ADMET profiling confirmed the compounds safety and drug-like characteristics. These findings underscore the potential of traditional phytochemicals to serve as lead candidates in antiviral drug development. This research bridges the gap between traditional medicine and modern computational techniques, paving the way for innovative and efficient therapeutic strategies against HMPV.
- organism: human
- assay: metagenomics
- research focus: drug response / drug discovery
- approach: statistical model
- approach: simulation
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Exploring FDA-Approved Antiviral Drugs for Human Metapneumovirus Treatment: Integrative Computational Insights
Amit Dubey, Manish Kumar, … Vivek Dhar Dwivedi·bioRxiv·Jan 13, 2025
- Harnessing Computational Insights to Identify Potent Inhibitors for Human Metapneumovirus (HMPV): A Synergistic Approach with Natural Compounds
Amit Dubey, Manish Kumar, … Vivek Dhar Dwivedi·bioRxiv·Jan 7, 2025
- Disrupting Viral Replication in Human Metapneumovirus: Targeting Key Proteins with Unani Phytochemicals through Structural Dynamics and Energetics
Amit Dubey·bioRxiv·Feb 16, 2025
- Repurposing Metal-Based Therapeutics for Human Metapneumovirus (HMPV): An Integrative Computational Approach
Amit Dubey, Manish Kumar, … Andrea Ragusa·Bioinorganic Chemistry and ApplicationsPeer-reviewed·Jan 1, 2025
- Identification of Antiviral Drug Candidates Against Monkeypox DNA Polymerase and Profilin-like Protein A42R Utilizing an In-Silico Approach
Muhammad Amjid, Muhammad Maroof Khan, … Tahir Muhammad·PLoS neglected tropical diseasesPeer-reviewed·Jul 29, 2025
- Drug repurposing for therapeutic discovery against human metapneumovirus infection
A. Van Den Bergh, P. Guillon, … L. Dirr·bioRxiv·Jul 24, 2022